CTLA4 and neoplasm: Although anti-Ly6C/CTLA-4 treatment achieved a significantly better outcome in terms of tumor growth and immune infiltration than that of anti-Ly6C/PD-1, dual blockade of Ly6C/CTLA-4 did not produce a curative effect (Figures S3A, B).